HACKENSACK, NJ / ACCESSWIRE / December 14, 2020 / Champions Oncology, Inc.
(NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery through innovative pharmacology, biomarker and data platforms, today announced its financial results for the second fiscal quarter ended October 31, 2020.
Second Quarter and Recent Highlights:
- Launched our Lumin Bioinformatics proprietary SaaS platform
- Delivered record quarterly revenue of $10.1 million, an increase of 33% year-over-year
- Reported income from operations, excluding stock-based compensation, depreciation and amortization, of $400,000
- Raising our full-year revenue guidance to 20%-25%